Mukund Pharmatek Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 13-12-2024
- Paid Up Capital ₹ 0.18 M
as on 13-12-2024
- Company Age 34 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 0.40%
(FY 2022)
- Profit 1036.99%
(FY 2022)
- Ebitda 2.25%
(FY 2022)
- Net Worth 12.20%
(FY 2022)
- Total Assets 10.91%
(FY 2022)
About Mukund Pharmatek
The Company is engaged in the Financial Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.18 M, as per Ministry of Corporate Affairs (MCA) records.
Sumit Aggarwal, Saurabh Aggarwalla, and Shashi Aggarwal serve as directors at the Company.
- CIN/LLPIN
U74899DL1990PTC041146
- Company No.
041146
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Aug 1990
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Mukund Pharmatek?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sumit Aggarwal  | Director | 02-Sep-2006 | Current |
| Saurabh Aggarwalla | Director | 02-Sep-2006 | Current |
| Shashi Aggarwal | Director | 31-Oct-2012 | Current |
Financial Performance of Mukund Pharmatek.
Mukund Pharmatek Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 0.4% increase. The company also saw a substantial improvement in profitability, with a 1036.99% increase in profit. The company's net worth Soared by an impressive increase of 12.2%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mukund Pharmatek?
In 2019, Mukund Pharmatek had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Shree Rani Sati Infotech Private LimitedActive 17 years 7 monthsSumit Aggarwal, Saurabh Aggarwalla and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Mukund Pharmatek?
Unlock and access historical data on people associated with Mukund Pharmatek, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mukund Pharmatek, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mukund Pharmatek's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
